Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Atopic Dermatitis in Young Children: Controversies, Concerns, and Current Guidelines

Description

The presentation discusses atopic dermatitis (AD) in young children, emphasizing its prevalence and impact on families, especially in urban settings like New York. It highlights the significant number of infants affected, with nearly one in five in the U.S. experiencing eczema. The speaker notes the anxiety parents feel and the critical questions they have about their child's condition and its potential lifelong implications. The discussion includes the different phenotypes of atopic dermatitis in infants versus older children, emphasizing the unique clinical presentation in infants, which often involves widespread body surface area and specific areas like the cheeks. The speaker reflects on the timeline of potential improvement, noting that while many infants tend to outgrow atopic dermatitis, a subset may continue to experience symptoms. Management strategies are introduced, including recent studies on preventative measures using emollients and the role of early intervention. The discussion extends to the complex relationship between atopic dermatitis and other atopic conditions like asthma and food allergies, revealing how different demographics may experience various outcomes. Finally, the importance of recognizing potential underlying immunodeficiencies in severe cases of atopic dermatitis is highlighted, as well as the need for a nuanced approach to treatment and management to alleviate both physiological symptoms and parental anxiety.

View more

Conclusions

  • Atopic dermatitis is a common condition in young children, with a significant prevalence in those under two years of age.
  • The severity and persistence of atopic dermatitis can vary greatly, with early onset potentially leading to a higher risk of developing other allergic conditions later in life.
  • Early intervention and management of atopic dermatitis can significantly improve outcomes and may prevent the progression to other atopic disorders.
  • Unique clinical characteristics of atopic dermatitis in infants necessitate targeted assessment and treatment approaches, including the potential for biologic therapies.
  • Studies indicate that certain maternal factors and early-life interventions can influence the development and persistence of atopic dermatitis and associated conditions.
  • Omalizumab may help in reducing allergic reactions in children with atopic dermatitis and multiple food allergies, indicating a potential overlap between eczema management and food allergy treatment.
  • Thorough monitoring of infants with atopic dermatitis for signs of primary immunodeficiencies is essential due to their increased risk for infections and other serious health issues.
  • Rentfrom PJ et al. Journal of Personality and Social Psychology. 2013
  • Chiesa AU et al. JID. 2019
  • Al-naqeeb J et al. Am Board Fam Med. 2019
  • Shaw TE et al. JID. 2011
  • Bieber T et al. J Allergy Clin Immunol 2017
  • Roduit C et al. JAMA Pediatrics 2017
  • McAleer MA et al. Br J Dermatol. 2018
  • Berdyshev B et al. J Allerg Clinical Immunol 2023
  • Geba G et al. J Allerg Clinical Immunol 2023
  • Milner J. Annu. Rev. Immunol. 2020
  • Biagini C et al. J Allerg Clinical Immunol 2022
  • Pichard DC, et al. JAAD. 2015
  • Zang Y et al. J Allergy Clin Immunol. 2014
  • Marrs T, et al; EAT Study Team. Br J Dermatol. 2020
  • Kramer MS, et al. BMJ 2007;335:815.
  • Li L et al . Am J Clin Dermatol 2019
  • Allergy. 2019 Nov;74(11):2212-2219